Agios Pharmaceuticals AGIO Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's change in other assets?
- Agios Pharmaceuticals (AGIO) reported change in other assets of $2.46M in Q1 2026.
- How has Agios Pharmaceuticals's change in other assets changed year-over-year?
- Agios Pharmaceuticals's change in other assets increased by 15.6% year-over-year, from $2.12M to $2.46M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.